Clinical Studies Sponsored by Argos Therapeutics

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

A Single-Patient Study Using AGS 006

An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)

Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer

RNA-Loaded Dendritic Cell Cancer Vaccine

Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

A Rollover Protocol for Subjects Previously Treated With AGS-003

Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma